Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Study of Inhaled Sodium Nitrite as an Antimicrobial for Pseudomonas Infection in Cystic Fibrosis

NCT02694393 is registered in ClinicalTrials.gov with Schmidhofer, Mark, MD as lead sponsor.

NCT NCT02694393
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02694393 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Study of Inhaled Sodium Nitrite as an Antimicrobial for Pseudomonas Infection in Cystic Fibrosis
Lead sponsor
Schmidhofer, Mark, MD
Phase
Phase 1/2
Overall status
Terminated
Start date
February 29, 2016
Completion date
July 21, 2022
Enrollment
4 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis